bushaid glp-1 EasyStart Offer by Helimeds GLP-1 Supplement for Weight Management

Data from the EFFISAYIL program show spesolimab provides: Sustained reduction in flare frequency over 3 years ~75% of patients remaining flare-free Stable safety profile with no new signals Given the severity and unpredictability of GPP, these findings reinforce the value of targeted IL-36 inhibition for durable disease suppression

CagriSema: GI adverse events in 79.6% of CagriSema group vs 39.9% placebo in REDEFINE 1

It encourages skin turnover without stripping or irritating your barrier

This effect may be explained by a DPP-4 inhibitor-dependent reduction in intestinal lipoprotein production and consecutive lowering of circulating chylomicrons (36, 37)

[1] Lastly, add turmeric to any meal for an anti-inflammatory benefit